People · Operator

Kelley T. Lipman

Named in public records as an officer, director or promoter · active 2023–2023 · Other

1
Companies
4
Filings
$50.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
CyMedica Orthopedics, Inc.OtherSeries B$50.0M$108.9M2023
Operator network

Kelley T. Lipman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Alexander B. Suh · 3 companies · 1 sharedAlexander B. SuhEdwin F. Scheetz · 3 companies · 1 sharedEdwin F. ScheetzChristopher B. Martin · 2 companies · 1 sharedChristopher B. Ma…D. Ronald Yagoda · 2 companies · 1 sharedD. Ronald YagodaRobert Morocco · 2 companies · 1 sharedRobert MoroccoChristopher H. Martin · 1 companies · 1 sharedChristopher H. Ma…Edwin F. Sheetz · 1 companies · 1 sharedEdwin F. SheetzJeff F. Zywicki · 1 companies · 1 sharedJeff F. ZywickiJeffrey T. Zywicki · 1 companies · 1 sharedJeffrey T. ZywickiRhonda F. Anderson · 1 companies · 1 sharedRhonda F. AndersonRhonda T. Anderson · 1 companies · 1 sharedRhonda T. AndersonStruan H. Coleman · 1 companies · 1 sharedStruan H. ColemanWilliam H. Hanna · 1 companies · 1 sharedWilliam H. HannaCyMedica Orthopedics, Inc. · $50.0M raisedCyMedica Orthopedics,…Kelley T. LipmanKL
Kelley T. Lipman Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Kelley T. Lipman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Alexander B. Suh13
Edwin F. Scheetz13
Christopher B. Martin12
Robert Morocco12
D. Ronald Yagoda12
Christopher H. Martin11
Rhonda F. Anderson11
Jeffrey T. Zywicki11
Rhonda T. Anderson11
Struan H. Coleman11
Edwin F. Sheetz11
Jeff F. Zywicki11
William H. Hanna11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.